For Immediate Release:
|
|
For Release 7 a.m. EDT
August 6, 2003
Loveland, OH and Oxford, UK, August 6th 2003 - Amphora Research Systems announced today that it has implemented a discovery research solution at Oxford BioMedica. Amphora Research Systems are a recognized leader in Electronic Laboratory Notebook solutions to better support the research activities of scientists. Oxford BioMedica personnel can now secure their original scientific records on loose-leaf security paper, acceptable to legal counsel, and additionally have access to a searchable, shareable repository of vital scientific activities.
Discovery research is a key activity for any Biotech organization. Creating and retaining accurate, signed and witnessed records is critical to protecting a company's investment in its Intellectual Property portfolio. The ability to successfully defend its Patents is essential to a Biotech's growth and stability, and assures potential revenues that arise from products developed.
Computers are an increasing part of R&D work, yet patent considerations mean most scientists have to document their research in a traditional bound paper lab notebook (BLN). This means a large amount of "Cut & Paste" involving real scissors and tape - and a lot of wasted time. This gap between their work (performed on computer) and the record keeping mechanism (BLN) is an increasing source of frustration and lost productivity for scientists all over the world. To make matters worse, BLNs obstruct the computer-facilitated searching and sharing which is key to working effectively as a team in today's modern organization.
Oxford Biomedica is using Amphora's PatentSafe™ solution to create records on PatentPad® security paper, which is then signed and witnessed as previously with their bound lab notebook. Oxford BioMedica's scientists use whatever PC based client tool they prefer (e.g. Word, Excel, LIMS client) to "assemble" the record, and then submit this to Amphora's PatentSafe™ application.
"Amphora's PatentSafe™ has enabled us to migrate from cumbersome, outdated bound laboratory notebooks to a computer-based record system, which still provides hard copy and signed and witnessed records to satisfy our intellectual property requirements." said Dr. Sue Kingsman, Executive Director & Senior Vice President, of Research. "In addition, PatentSafe™ provides us with a searchable, shareable file system for all our records."
Simon Coles, President & COO, Amphora Research Systems, said: "We have been proud to work with Oxford BioMedica to deliver a cost-effective replacement for their bound lab notebooks. We were aware that Research Scientists are becoming increasingly frustrated with the need to keep bound lab notebooks, when a significant amount of work is performed on computers. Oxford BioMedica has demonstrated how a leading biotech organization can increase their scientists' productivity and capability to collaborate, while producing better records for the defence of their Intellectual Property."
About Oxford BioMedica: Oxford BioMedica (OXB: LSE) specialises in the development of novel gene-based therapeutics for the treatment of cancer, neurodegenerative diseases and other disorders with major unmet clinical needs. The development pipeline includes two novel anti-cancer products in clinical trials and a gene therapy treatment for Parkinson's disease, which is in late preclinical studies. This is underpinned by a broad research pipeline and over 70 patent families.
Oxford BioMedica is headquartered in Oxford, UK, and has a fully owned subsidiary, BioMedica Inc, in San Diego, USA. BioMedica Inc is focused on gene-based therapies for neurological diseases and is progressing relations with the FDA for clinical trial development.
About Amphora Research Systems: Amphora Research Systems provides cost-effective alternatives to the bound paper lab notebook which are more appropriate for the computer age, yet still fulfil legal counsel's requirement for evidence to support Patent claims in the event of dispute. Amphora's solutions are in use by companies large and small, and support a wide variety of scientific activity.
Amphora Research Systems Ltd. has offices in Bracknell, UK, and Cincinnati, USA. Amphora is focused on Electronic Laboratory Notebooks for non-regulated users.
For further information, please contact: ·
Tom Ryan
Amphora Research Systems
Tel: 513 697 4764
Email: tomr@amphora-research.com
or pr@amphora-research.com
Web site: http://www.amphora-research.com/
Oxford BioMedica
Tel: +44 (0)1865 783000
Email: enquiries@oxfordbiomedica.co.uk
The Collaborative Electronic Notebook Systems Association
(781) 395-3004, ext 201
# # #
This press release may contain certain statements that are forward-looking and involve risks and uncertainties. Words such as "expects," "anticipates," "projects," "estimates," "intends," "plans," "believes," variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are based on current expectations and projections made by management and are not guarantees of future performance. Therefore, actual events, outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. We have identified certain factors that could cause actual results to differ materially from the forward-looking statements in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, and our Current Reports on Form 8-K. Except as otherwise required under federal securities laws and the rules and regulations of the SEC, we do not have any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, changes in assumptions or otherwise.
# # #
